文献库 文献相关信息

题目:
Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.
作者:
Scélo(Ghislaine),Boffetta(Paolo),Corbex(Marilys),Chia(Kee-Seng),Hemminki(Kari),Friis(Soren),Pukkala(Eero),Weiderpass(Elisabete),McBride(Mary L),Tracey(Elizabeth),Brewster(David H),Pompe-Kirn(Vera),Kliewer(Erich V),Tonita(Jon M),Martos(Carmen),Jonasson(Jon G),Brennan(Paul)
状态:
发布时间2007-03-05 , 更新时间 2009-02-12
期刊:
Cancer Causes Control
摘要:
To study the risk of second primary cancers in nasopharyngeal carcinoma (NPC) patients and the risk of NPC as second primary cancer.,We used data from the cancer registries from Singapore and from 12 low-incidence areas, including a total of 8,947 first occurring NPC cases, and 167 second occurring cases. We calculated standardized incidence ratios (SIRs) by comparing the second cancer incidence in NPC patients to the first primary cancer incidence in non-cancer population. We also calculated SIRs of second NPC after other primaries.,In Singapore, the risk of cancers of the lung (SIR=0.42), stomach (SIR=0.41), and colon (SIR=0.23) was significantly decreased after NPC, whereas that of cancer of the tongue (SIR=11.1) was significantly increased. In Australia, Canada, and Europe, the risk of non-Hodgkin's lymphoma (NHL) (SIR=3.06), tongue cancer (SIR=5.29), brain cancer (SIR=3.89), myeloid leukemia (SIR=3.85), and non-melanoma skin cancer (NMSC) (SIR=3.47) was significantly increased after NPC. Incidences of second occurring NPCs following various primary cancers were not significantly altered compared to the incidence of first occurring NPCs.,Immune suppression (NHL, NMSC), shared genetic factors (lung cancer, NHL, myeloid leukemia), and shared environmental risk factors (tongue and brain cancers) might explain the associations. Except for NHL, there was no evidence of association with other Epstein-Barr virus-related cancers.
语言:
eng
DOI:
10.1007/s10552-006-0101-z

联系方式

山东省济南市 高新区 崇华路359号 三庆世纪财富中心C1115室

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。